Risedronate Preserves Bone Architecture in Early Postmenopausal Women in 1 Year as Measured by Three-Dimensional Microcomputed Tomography

Calcified Tissue International

Volumn 73, Issue 5, 2003, Pages 423-432

  Dufresne, T E ^a   Chmielewski, P A ^a   Manhart, M D ^a   Johnson, T D ^a   Borah, B ^a  

^a PROCTER AND GAMBLE PHARMACEUTICALS   (United States)

Author keywords

Bone loss; Microcomputed tomography; Osteoporosis; Risedronate; Trabecular architecture

Indexed keywords

RISEDRONIC ACID;

ADULT; ARTICLE; BONE BIOPSY; BONE DENSITY; BONE MARROW; BONE MINERALIZATION; BONE STRUCTURE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; HUMAN TISSUE; ILIAC CREST; LUMBAR SPINE; OSTEOLYSIS; POROSITY; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; THICKNESS; THREE DIMENSIONAL IMAGING; TRABECULAR BONE;

BONE DENSITY; CALCIUM CHANNEL BLOCKERS; DENSITOMETRY, X-RAY; DOUBLE-BLIND METHOD; ETIDRONIC ACID; FEMALE; HUMANS; ILIUM; IMAGING, THREE-DIMENSIONAL; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; TOMOGRAPHY SCANNERS, X-RAY COMPUTED;

EID: 0345604388     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-002-2104-4     Document Type: Article

References (46)

1. Cummings SR, Black DM, Vogt TM (1996) Changes in BMD substantially underestimate the anti-fracture efficacy of alendronate and other anti-resorptive drugs. J Bone Miner Res 11:S102
2. Sarkar S, Mitlak BH, Wong M, Stock JL, Black DM, Harper KD (2002) Relationship between bone mineral density and incident vertebral fracture risk with raloxifene therapy. J Bone Miner Res 17:1-10
3. Watts N, Bockman R, Smith C, Li Z, Eastell R, Pack S, Lindsay R (2000) BMD changes explain only a fraction of the observed fracture risk reduction in risedronate-treated patients. Osteoporos Int (suppl 2):546, S203
4. Riggs BL, Melton III LJ, O'Fallon WM (1996) Drug therapy for vertebral fractures in osteoporosis: evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficiency. Bone 18(suppl): 197S-201S
5. Parfitt AM 2002 (1996) Skeletal heterogeneity and the purpose of bone remodeling: Implications for the understanding of osteoporosis. In: Marcus R, Feldman D, Kelsey J (Eds.) Osteoporosis. Academic Press, San Diego, CA, USA, pp 315-329
6. Chestnut III CH, Rosen CJ (2001) Reconsidering the effects of antiresorptive therapies in reducing osteoporotic fracture. J Bone Miner Res 16:2163-2172
7. Turner CH (2002) Biomechanics of bone: determinants of skeletal fragility and bone quality. Osteoporos Int 13:97-104
8. Harris ST, Watts NB, Genant HK, et al. for the Vertebral Efficacy With Risedronate Therapy (VERT) Study Group (1999) Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis. JAMA 282:1344-1352
9. Reginster J-Y, Minne HW, Sorensen OH, et al. on behalf of the Vertebral Efficacy with Risedronate Therapy (VERT) Study Group (2000) Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Osteoporos Int 11:83-91
10. Wallach S, Cohen S, Reid DM, et al. (2000) Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy. Calcif Tissue Int 67:277-285
11. Li Z, Meredith MP, Hoseyni M (2001) A method to assess the proportion of treatment effect explained by a surrogate endpoint. Stat in Med 20:3175-3188
12. Eastell R, Barton I, Hannon RA, Chines A, Garnero P, Delmas PD (2003) Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate. J Bone Miner Res 18:1051-1056
13. Parfitt AM (1992) Implications of architecture for the pathogenesis and prevention of vertebral fracture. Bone 13:S41-S47
14. Dempster DW, Cosman F, Kurland ES, et al. (2001) Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study. J Bone Miner Res 16:1846-1853
15. Nuzzo R, Lafage-Proust MH, Martin-Badosa E, Boivin G, Thomas T, Alexandre C, Peyrin F (2002) Synchrotron radiation microtomography allows the analysis of three-dimensional microarchitecture and degree of mineralization of human iliac crest biopsy specimens: effects of etidronate treatment. J Bone Miner Res 17:1372-1382
16. Mortensen L, Charles P, Bekker PJ, Digennaro J, Johnston CC (1998) Risedronate increases bone mass in an early postmenopausal population: two years of treatment plus one year of follow-up. J Clin Endocrinol Metab 83:396-402
17. Eriksen EF (1986) Normal and pathological remodeling of human trabecular bone: three-dimensional reconstruction of the remodeling sequence in normals and in metabolic bone disease. Endocr Rev 7:379-408
18. Ruegsegger P, Koller B, Muller R (1996) A microtomographic system for the nondestructive evaluation of bone architecture. Calcif Tissue Int 58:24-29
19. Chmielewski PA (1999) Validation of a micro-CT system for the 3-D measurement of bone. Presented at the VIIIth Congress of the International Society of Bone Morphometry. Scottsdale, AZ, Oct 6-10, 1999
20. Dufresne TE (1998) Segmentation techniques for analysis of bone by three-dimensional computed tomographic imaging. Technol Health Care 6:351-359
21. Hildebrand T, Ruegsegger P (1997) A new method for the model-independent assessment of thickness in three-dimensional images. J Microsc 185:67-75
22. Hildebrand T, Laib A, Muller R, Dequeker J, Ruegsegger P (1999) Direct three-dimensional morphometric analysis of human cancellous bone: microstructural data from spine, femur, iliac crest, and calcaneus. J Bone Miner Res 14:1167-1174
23. Odgaard A, Gundersen HJ (1993) Quantification of connectivity in cancellous bone, with special emphasis on 3-D reconstructions. Bone 14:173-182
24. Vesterby A (1993) Marrow space star volume can reveal change of trabecular connectivity. Bone 14:193-197
25. Borah B, Dufresne TE, Cockman MD, Gross GJ, Sod EW, Myers WR, Combs KH, Higgins RE, Pierce SA, Stevens ML (2000) Evaluation of changes in trabecular bone architecture and mechanical properties of minipig vertebrae by three-dimensional magnetic resonance microimaging and finite element modeling. J Bone Miner Res 15:1786-1797
26. Borah B, Dufresne TE, Chmielewski PA, Gross GJ, Prenger MC, Phipps RJ (2002) Risedronate preserves trabecular architecture and increases bone strength in vertebra of ovariectomized minipigs as measured by 3-D microcomputed tomography. J Bone Miner Res 17:1139-1147
27. Dempster DW (1995) Bone remodeling. Osteoporosis. In: Riggs BL, Melton III LJ (Eds.) Etiology diagnosis and management, 2nd ed. Lippincott_Raven, Philadelphia, pp 67-91
28. Kanis J (1996) Textbook of osteoporosis. Blackwell Science Ltd, Cambridge, Mass
29. Parfitt AM, Mathews CH, Villanueva AR, Kleerekoper M, Frame B, Rao DS (1983) Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss. J Clin Invest 72:1396-1409
30. Heaney RP, Yates AJ, Santora II AC (1997) Bisphosphonate effects and the bone remodeling transient. J Bone Miner Res 12:1143-1151
31. Delmas PD (2000) How does anti-resorptive therapy decrease the risk of fracture in women with osteoporosis. Bone 27:1-3
32. Boivin GY, Chavassieux PM, Santora AC, Yates J, Meunier PJ (2000) Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women. Bone 27:687-694
33. Roschger P, Rinnerthaler S, Yates J, Rodan GA, Fratzl P, Klaushofer K (2001) Alendronate increases degree and uniformity of mineralization in cancellous bone and decreases the porosity in cortical bone of osteoporotic women. Bone 29:185-191
34. Day J, Ding M, Bednarz P, et al. (2002) Transactions of the 48th Annual Orthopaedic Research Society Meeting, 27:85
35. Silva MJ, Gibson LJ (1997) Modeling the mechanical behavior of vertebral trabecular bone: effects of age-related changes in microarchitecture. Bone 21(Supp 2):191-199
36. Chappard D, Legrand E, Basle MF, Fromont P, Racineux JL, Rebel A, Audran M (1996) Altered trabecular architecture induced by corticosteroids: a bone histomorphometric study. J Bone Miner Res 11:676-685
37. Ulrich D, van Rietbergen B, Laib A, Ruegsegger P (1999) The ability of three-dimensional structural indices to reflect mechanical aspects of trabecular bone. Bone 25:55-60
38. Borah B, Dufresne TE, Chmielewski PA, Prenger MC, Eriksen EF (2001) Risedronate (Ris) preserves bone architecture in osteoporotic postmenopausal women as measured by 3-D microcomputed tomography (abstract). J Bone Miner Res 16(suppl 1):S218
39. Eriksen E, Melsen F, Sod E, Barton I, Chines A (2002) Effects of long-term risedronate on bone quality and bone turnover in women with postmenopausal osteoporosis. Bone 31:620-625
40. Jiang Y, Zhao J, Eriksen EF, Wang O, Genant HK, Mitlak BH (2002) Improved 3-dimensional microarchitecture of cancellous and cortical bone in a multicenter, double-blind, randomized and placebo-controlled study of Teriparatide [rhPTH(1-34) (abstract). J Bone Miner Res 17(suppl 1):S135
41. Meunier P, Courpron P, Edouard C, Bernard J, Bringuner J, Vignon G (1973) Physiological senile involution and pathological rarefaction of bone. Clin Endocrinol Metab 2:239-256
42. Oleksik A, Ott SM, Vedi S, Bravenboer N, Compston J, Lips P (2000) Bone structure in patients with low bone mineral density with and without vertebral fractures. J Bone Miner Res 15:1368-1375
43. Kimmel DB, Recker RR, Gallagher JC, Vaswani AS, Aloia JF (1990) A comparison of iliac bone histomorphometric data in post-menopausal osteoporotic and normal subjects. Bone Miner 11:217-235
44. Kleerekoper M, Villanueva AR, Stanciu J, Rao DS, Parfitt AM (1985) The role of three-dimensional trabecular microstructure in the pathogenesis of vertebral compression fractures. Calcif Tissue Int 37:594-597
45. Mosekilde L, Viidik A, Mosekilde L (1985) Correlation between the compressive strength of iliac crest and vertebral trabecular bone in normal individuals. Bone 6:291-295
46. Delmas PD (2002) Different effects of antiresorptive therapies on vertebral and nonvertebral fractures in post-menopausal osteoporosis. Bone 30:14-17